The Caenorhabditis elegans EGL-26 Protein Mediates Vulval Cell Morphogenesis  by Hanna-Rose, Wendy & Han, Min
Developmental Biology 241, 247–258 (2002)
doi:10.1006/dbio.2001.0514, available online at http://www.idealibrary.com onThe Caenorhabditis elegans EGL-26 Protein
Mediates Vulval Cell Morphogenesis
Wendy Hanna-Rose1 and Min Han
Howard Hughes Medical Institute and Department of Molecular, Cellular and
Developmental Biology, University of Colorado, Boulder, Colorado 80309
In screens for Caenorhabditis elegans mutants defective in vulval morphogenesis, we isolated multiple mutants in which
the uterus and the vulva fail to make a functional connection, resulting in an egg-laying defective phenotype. Two of these
connection of gonad defective (Cog) mutants carry alleles of the egl-26 gene. We demonstrate that vulval lineages in egl-26
mutant animals are normal, but one vulval cell, vulF, adopts an abnormal morphology. This results in formation of an
abnormally thick layer of vulval tissue at the apex of the vulva and a physical blockage of the exit to the vulva from the
uterus. egl-26 was cloned and is predicted to encode a novel protein. Mosaic analysis indicates that egl-26 activity is
required in the primary vulval lineage for vulF morphogenesis. Expression of a functional translational fusion of EGL-26 to
GFP was observed within the primary vulval lineage only in vulE, which neighbors vulF. EGL-26 is localized at the apical
edge of the vulE cell. It is thus possible that vulE acts to instruct morphological changes in the neighboring cell, vulF, in
an interaction mediated by EGL-26. © 2001 Elsevier Science
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Organogenesis, the formation of functional organs, re-
quires complex developmental coordination among groups
of cells of various fates as they remodel themselves into
functional structures. Additionally, in order to ensure
proper function, there must be strict coordination of the
spatial development of groups of organs that require mutual
physical interaction for function. An elucidation of the
molecular mechanisms controlling cellular remodeling dur-
ing organogenesis and the coordination of distinct organo-
genesis events will contribute to our understanding of organ
developmental pathologies.
Progress has been made investigating organogenesis in a
number of systems, including kidney (Cantley, 1996), tooth
(Peters and Balling, 1999), lung and Drosophila trachea
(Metzger and Krasnow, 1999), and flower morphogenesis
(Lord et al., 1994). Primarily, this research has led to a
deeper understanding of how cell fates are specified within
different tissues. However, the genetic control of the later
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All rights reserved.remodeling processes that these specified cells undergo is
still largely unexplored. We are using development of the
vulva in Caenorhabditis elegans as a model system to
address questions of how organogenesis is genetically con-
trolled and effected. Additionally, we are studying the
formation of the vulval-uterine connection to understand
how organogenesis of two organs can be coordinated. In C.
elegans hermaphrodites, the tubular vulva, which arises
from only 22 cells, connects the uterus to the outside of the
body allowing passage of eggs and sperm during egg-laying
and mating, respectively. The simplicity of the structure,
the well-elucidated control of vulval cell-fate determina-
tion decisions, and the fact that the organ is nonessential
for viability, allowing it to be easily genetically manipu-
lated, make vulval development a powerful model system
to study organogenesis.
Three precursor cells, P5.p, P6.p, and P7.p, adopt vulval
cell fates in response to an inductive signal that activates a
conserved Ras-mediated signaling pathway in the precursor
cells (reviewed in Greenwald, 1997; Kornfield, 1997; Stern-
berg and Han, 1998). The inductive signal originates from
the anchor cell (AC), a specialized cell of the somatic gonad.
Appropriate fate determination also requires lateral signal-
ing between the vulval precursor cells, involving activation
of a conserved Notch-mediated signaling pathway (re-
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events, P6.p adopts a primary (1°) vulval cell fate and
produces eight vulval cell progeny (Fig. 1). In contrast, P5.p
and P7.p adopt secondary (2°) vulval cell fates and produce
seven progeny each (Fig. 1). The first two rounds of division
in the vulval lineages occur along a longitudinal division
axis. However, during the third, terminal division, each
dividing cell reproducibly chooses either a transverse or
longitudinal division plane, placing each of the 22 vulval
cells in a characteristic and reproducible position within
the vulva (Fig. 1).
Drastic morphological changes in vulval cells begin to
occur following the terminal divisions. Most strikingly,
cells from the anterior and posterior sides of the vulva send
FIG. 1. Vulval structure. The vulva is formed from three precur-
sor cells, P5.p, P6.p, and P7.p. P6.p adopts a primary (1°) fate and
produces eight progeny. The terminal divisions in the 1° lineage
occur with a transverse (T) axis of division. P5.p and P7.p adopt a
secondary (2°) fate and produce seven progeny each. The distal two
granddaughters of each 2° cell divide in the longitudinal (L) plane,
the most proximal granddaughters do not divide (N) in the final
division, and the remaining granddaughters divide transversely (T).
The 22 generated vulval cells undergo a set of specific migrations
and fusions to form 7 stacked toroids (cut away here to reveal the
central lumen), called vulA, -B1, -B2, -C, -D, -E, and -F. The 1°
lineage gives rise to only vulE and vulF. vulB1 and vulB2 are
composed of two mononucleate cells. Cell–cell fusions produce a
binucleate vulD cell and tetranucleate cells in all other cases.
Nuclei (dots) that arose from a transverse division are located on
the lateral sides of the animal, and nuclei that arose from lateral
divisions are located at or close to the midline plane.out processes proximally and laterally. These processes pass
© 2001 Elsevier Science. Aunderneath their inside proximal neighbors, driving a dorsal
shift to form a large invagination (Sharma-Kishore et al.,
1999). As anterior cell processes reach the lateral sides, they
either fuse or form tight junctions with their corresponding
anterior cell partners to form toroids composed of
multinucleate cells or a set of two mononucleate cells,
respectively. Ultimately, a series of seven, stacked toroids
form the walls of the vulva, surrounding a central lumen
(Fig. 1). Nuclei placement remains fixed in the multinucle-
ate toroids. Nuclei that arose from a transverse division
remain on the lateral sides of the animal after fusion, while
nuclei that arose from a longitudinal division remain close
to the midline plane.
The vulval toroids are named vulA, -B1, -B2, -C, -D, -E,
and -F (Fig. 1). The fusion events that lead to formation of
the toroids occur with an established temporal sequence
during the fourth larval stage of C. elegans development.
VulD fuses first, followed sequentially by vulA, -C, -F, and
-E, while vulB1 and vulB2 remain unfused (Fig. 1) (Sharma-
Kishore et al., 1999). In this manner, the vulval cell fates
called 1° and 2° are further refined into seven different fates,
such that the 1° lineage of P6.p gives rise to the dorsal-most
vulval cells vulE and vulF, while the remaining five toroids
arise from 2° lineages (Fig. 1). Although specification of 1°
and 2° fate determination is well understood, resolution of
toroid fates after the terminal divisions remains unclear, as
are the genetic mechanisms underlying the dramatic
changes in cell morphology that occur during vulval orga-
nogenesis.
To identify genes that play roles in this remodeling
process, we screened for mutants with abnormal vulval
morphology. We have focused on mutants that fail to make
a proper connection between the vulva and the uterus in
order to also examine the coordination between two orga-
nogenesis events. In this work, we present an analysis of the
egl-26 gene. We demonstrate that egl-26 encodes a novel
protein that acts to specify the precise morphology of vulF,
the dorsal-most toroid, promoting a proper connection
between the vulval and uterine lumens. Furthermore, we
examine the expression pattern which suggests that this
novel protein adopts an interesting subcellular localization
and functions in a non-cell-autonomous manner.
MATERIALS AND METHODS
General Methods and Strains
We maintained strains at 20°C using standard methods (Brenner,
1974; Wood, 1988). We used the following alleles and strains
(Riddle et al., 1997; or as referenced): N2 (Bristol), RW7000 (Berge-
rac) (Williams, 1995), MT681 nDf3/lin-31(n301) bli-2(e768) II
(Greenwald and Horvitz, 1980), SU93 jcIs1[pRF4 pJS191
C45D3(unc-291)] IV (Mohler et al., 1998), LG II: ku211 and ku228
(this paper), n481 (Trent et al., 1983), e1932 (Hodgkin, 1986),
dpy-10(e128), unc-4(e120); LGIII: unc-119(ed3), unc-36(e251), LG
V: him-5(e1490). We captured images using an Axioskop or Axio-
plan2 microscope and a Hamamatsu C4742–95 CCD camera
(Hamamatsu Photonics KK, Bridgewater, NJ). A stack of images
ll rights reserved.
249egl-26 Mediates Vulval Morphogenesistaken in the Z plane at 0.5 mm intervals was deconvolved and
analyzed by using Openlab 2.0.7 (Improvision, Lexington, MA)
software. Adobe Photoshop 6.0 and Canvas 7 were used to prepare
images.
Isolation, Mapping, and Rescue of egl-26 Mutants
We isolated two recessive alleles, ku211 and ku228, in screens
for abnormal vulval morphology mutants (Hanna-Rose and Han,
1999). In brief, egg-laying defective (Egl) hermaphrodites were
identified in the F2 generation of animals treated with 50 mM
ethylmethane sulfonate (EMS) and were subjected to a secondary
screen in which the morphology of the vulva was observed by using
DIC microscopy. We outcrossed ku211 and ku228 at least six
times. ku211 was mapped to the left end of chromosome II; e.g.,
0/11 Dpy non-Unc and 10/10 Unc non-Dpy recombinants from
dpy-10 unc-4/ku211 heterozygotes segregated ku211. We further
refined the gene position using sequence-tagged site mapping
(Williams, 1995). ku211 heterozygous males were crossed to
RW7000 (Bergerac) hermaphrodites. ku211 homozygotes were re-
covered from the F2 generation and tested individually by PCR for
the presence of sequence-tagged sites stP100 and stP196. Both
markers were found in 3/70 mutants and 11/70 had stP196 only,
placing ku211 to the left of stP100. ku211 and ku228 mapped to the
same location, were rescued by the same cosmid (data not shown),
and were found to be alleles of egl-26 as ku211 fails to complement
egl-26(n481) (data not shown).
We generated transgenic strains by germline transformation
(Mello et al., 1991). Cosmid (5–20 mg/ml) obtained from A. Coulson
(Sanger Center) or plasmid was coinjected with the transformation
markers pTG96 (sur-5::gfp) (Gu et al., 1998) at 100 mg/ml or pRF4
(rol-6) (Mello et al., 1991) at 70 mg/ml into ku211, ku228, or
ku211/dpy-10 unc-4 hermaphrodites. We scored restoration of
egg-laying ability as positive rescuing activity. Cosmid C36F12 and
the subclones pWH8 and pWH11 (see below) rescued (data not
shown).
Plasmid Construction and cDNA Cloning
A 13-kbp BamHI fragment from C36F12 was ligated to pBlue-
script to create pWH8, which was digested with SalI and religated
to make pWH11. To make pWH15, the GFP translational fusion,
the region between the SacI site in the gene and the last codon was
amplified by using primers that introduce SalI and BamHI sites on
the 59 and 39 ends, respectively, and cloned into the SalI and BamHI
sites of pPD95.77 (A. Fire, S. Xu, J. Ahnn, and G. Seydoux, personal
communication). The remaining egl-26 coding and regulatory re-
gions were added by digesting with SalI and SacI and ligating to the
5.7-kbp SalI–SacI fragment from pWH11. The ApaI–BamHI frag-
ment was exchanged between pWH15 and pPD95.69 (A. Fire, S. Xu,
J. Ahnn, and G. Seydoux, personal communication) to add a nuclear
localization signal, creating pWH16. To produce pWH22, the GFP
transcriptional fusion, the egl-26 coding region was removed from
pWH16 by replacing the NsiI–BamHI fragment with an amplified
fragment containing the region between the promoter NsiI site and
an engineered BamHI site after the start codon.
The gfp fusions were injected into unc-119(ed3) animals with an
unc-1191 construct (Maduro and Pilgrim, 1995). The resulting
extrachromosomal arrays are kuEx90 (pWH15) and kuEx115
(pWH22). kuEx115 was integrated as described (Mello and Fire,
1995) to form kuIs36.A 2100-bp NheI–MluI genomic fragment from pWH11 encoding
© 2001 Elsevier Science. Aall of C23H3.1 was used to probe the Stratagene (La Jolla, CA)
Nematode UniZap XR l mixed-stage cDNA library. From one-
million plaques, one positive clone (#7) was isolated and se-
quenced. Sequencing confirmed the Genefinder (Wilson et al.,
1994) predicted structure. The cDNA contained a 27-bp 59 se-
quence with in-frame stop codons prior to the ATG start, a 951-bp
open reading frame, and a 326 bp 39 UTR. Molecular lesions were
identified by sequencing amplified genomic DNA from lysates of
mutant animals.
Mosaic Analysis
We created multiple lines of transgenic animals by injecting
ku211 hermaphrodites with 10 mg/ml pWH11(egl-261) and 100
mg/ml sur-5::gfp or injecting ku211; unc-36(e251) hermaphrodites
with 10 mg/ml pWH11, 50 ng/ml pR1P16 (unc-361) (Herman et al.,
1995) and 100 mg/ml sur-5::gfp. Mosaics were identified by exam-
ining transgenic animals with a dissecting microscope equipped
with a mercury lamp for L4 to young adult stage animals with
mosaic patterns of green fluorescence or for partially or fully
uncoordinated animals that still retained fluorescence (Yochem et
al., 1998). We assessed mosaicism by examining a specified set of
nuclei within each lineage for the presence of fluorescence (Table
1). We then recovered mosaics from the slide and scored the next
day for egg-laying activity.
RESULTS
Mutation of egl-26 Results in a Vulval Morphology
Defect
We identified multiple mutants with a connection of
gonad defective (Cog) phenotype in screens for C. elegans
vulval morphogenesis defective mutants (Hanna-Rose and
Han, 1999). Cog mutants fail to make a proper connection
TABLE 1
Mosaic Analysis
Lineage Cells scored in each lineagea
ABal RID, ALA, ASKL, ADLL
ABar I5
ABpla ASIL, PLML, VPC or progeny, ALNL
ABplp excretory cell, hyp8/9, hyp10, rectal epithelium D
ABpra ASKR, ADLR, ASIR, PLMR, VPC or progeny
ABprp DVA, 1 body muscle, hyp8/9, hyp10
MSaa 4 body muscles
MSap posterior distal tip cell, AC, left ventral coelomocytes,
9 body muscles, dorsal coelomocytes
MSpa 6 body muscles
MSpp anterior distal tip cell, AC, right ventral
coelomocytes, 9 body muscles
E all intestinal cells
C hyp 11, DVC, 32 body muscles
D 20 body muscles
a Origins and names of cells based on Sulston et al. (1983).between the vulval and uterine lumens. Two of the identi-
ll rights reserved.
250 Hanna-Rose and Hanfied alleles, ku211 and ku228, are allelic to n481 and e1952,
two alleles of a previously uncharacterized gene called
egl-26 (under Materials and Methods) (Trent et al., 1983).
egl-26 mutant hermaphrodites display a varyingly pen-
etrant egg-laying defective (Egl) phenotype (Table 2). Prog-
eny of egl-26 Egl hermaphrodites hatch in the uterus and
kill the mother. As a result of the shortened reproductive
life, egl-26 hermaphrodites have diminished brood sizes
relative to a wild-type brood size of approximately 300
(Table 2). However, brood sizes of egl-26 mutant animals
that are able to lay eggs can approach wild-type levels
(Table 2). Two egl-26 alleles are associated with a low
percentage of sterile animals (Table 2), but this low pen-
etrance phenotype has not been further investigated. Al-
though egl-26 mutant phenotypes are not completely pen-
etrant, when egl-26(ku211) is placed in trans to a deficiency
that removes the egl-26 locus, the phenotype becomes
quantitatively slightly more severe than the ku211 ho-
mozygous controls (Table 2) but remains qualitatively the
same, suggesting that ku211 and the similar allele ku228
are hypomorphic mutations.
The egl-26 Egl phenotype is correlated with a specific
vulval morphology defect. Eighty-three percent of ku228
hermaphrodites are Egl (Table 2) and 87% (n 5 68) display a
Cog phenotype caused by thick disorganized tissue at the
apex of the vulva (Fig. 2). This thick tissue blocks the exit to
the vulva from the uterus and most likely results in the Egl
phenotype. The thickened tissue at the apex of the vulva
obscures the observation of the uterine seam cell (utse) that
normally separates the vulval and uterine lumens (Fig. 2A;
Newman et al., 1996). A failure to form the utse (Newman
et al., 1996) or a failure of the utse and anchor cell (AC) to
fuse during the fourth larval stage (Hanna-Rose and Han,
1999) could account for a Cog phenotype. Although the utse
is difficult to see in egl-26 mutants (Fig. 2B), we confirmed
its presence and normal utse-AC fusion by microscopic
observation of AC behavior and expression of cdh-3::gfp and
TABLE 2
Phenotype of egl-26 Mutants
Allele na % Eglb % Steril
ku228 53 83 4
ku211 52 75 0
e1952 53 66 9
n481 53 55 0
unc-4 ku211 52 63 0
unc-4 ku211/nDf3 34 88 9
a n is the number of animals scored.
b Percentage of animals with egg-laying defect. A few animals la
c Percentage of animals that produced no progeny.
d Percentage of animals that laid more than 20 eggs.
e “nd” is not determined.cog-2::gfp marker proteins (data not shown).
© 2001 Elsevier Science. AIn wild-type animals, the nuclei within vulE and vulF are
located on the lateral sides of the animal as a result of the
transverse, terminal divisions in the 1° lineage. In egl-26
mutants, vulF nuclei are often abnormally located in the
midline plane of the animal (e.g., Fig. 2C). Abnormal
placement of the vulF nuclei is not a result of an incorrect
division plane during the terminal division of the 1° lineage.
egl-26 mutants are indistinguishable from wild-type ani-
mals by Nomarski microscopy observations until the
middle of the fourth larval (L4) stage of vulval development,
hours after the terminal divisions are complete (data not
shown). However, during L4, the nuclei take up abnormal
positions and the apex adopts a disorganized appearance
(Fig. 2).
vulF Adopts an Abnormal Morphology in egl-26
Mutants
Because the apex of the vulva appears disorganized and
vulF nuclei sometimes occupy aberrant positions in egl-26
mutants, we made a closer examination of the vulval toroid
structure for any abnormalities. Similar to visualization of
the toroid structure using MH27 indirect immunofluores-
cence, expression of a jam-1::gfp fusion protein permits
observation of the vulval toroid structure in transgenic
animals (Sharma-Kishore et al., 1999; Shemer and Pod-
bilewicz, 2000). The epitope for the monoclonal antibody
MH27, encoded by the jam-1 gene, is localized to adherens
junctions between epithelial cells including the specialized
epithelia of the vulva (Raich et al., 1999). By performing
deconvolution and 3-D reconstruction on a series of fluo-
rescent images through multiple planes of the vulva in an
animal carrying jam-1::gfp on the integrated array, jcIs1, we
can visualize the toroidal structure as the space between
the rings that separate each toroid (Fig. 3). In wild-type
animals at the mid-L4 stage, vulE and vulF have not yet
fused. Thus, lateral junctions are visible between the ante-
% nonEgld
Brood size of:
Egl (n 5 12) nonEgl (n 5 5)
13 52.5 6 8 135.0 6 12
25 60.7 6 11 244.2 6 28
25 55.1 6 11 248.0 6 56
45 56.6 6 18 nde
37 nd nd
3 nd nd
ss than 20 eggs before becoming Egl.ec
id lerior and posterior halves of vulE and vulF (Figs. 3A and 3C).
ll rights reserved.
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form the narrowest rings in the vulva, making vulE appear
to form a narrow collar near the top of the vulva (Figs. 3A
and 3C). Although vulF is narrow on the ventral side
adjacent to vulE, it flares above vulE to form the wider apex
FIG. 2. egl-26 mutants fail to make a proper connection between
the vulval and uterine lumens. Nomarski photomicrographs from
the lateral side of (A) wild-type and (B, C) egl-26(ku211) mid-L4-
stage vulvae. (A) The closed arrow indicates the uterine seam cell
(utse) cytoplasm at the apex of the wild-type vulva. (B, C) The utse
is not visible in egl-26(ku211) animals. Instead, the apex of the
vulva is composed of disorganized tissue of vulval origin (open
arrow). “F” indicates vulF nuclei abnormally visible in the midline
plane. v, vulval lumen; u, uterine lumen. Bar, 5 mm.of the vulva (Figs. 3A and 3C). The junctions between vulF
© 2001 Elsevier Science. Aand uterine cells at the apex of the vulva form a ring just as
wide as the widest vulval toroids (brackets in Figs. 3A and
3C).
In egl-26 mutants, the structure of each toroid, except
vulF, resembles wild type (Figs. 3B and 3D). vulE again
forms a narrow collar near the top of the vulva. However,
vulF fails to flare above vulE and, instead, extends directly
dorsally to the apex, such that the apex is narrow, only
1/3–1/2 the width of the widest jam-1::gfp rings (brackets in
Figs. 3B and 3D). The abnormal morphology of the vulval
apex can also be observed by examining jam-1::gfp rings
from a ventral perspective. In wild-type animals, the apex
forms a large diamond-shaped ring that is as wide as the
other rings and that is largely open in the center (Fig. 3E). In
contrast, in egl-26 mutants, the diamond-shaped apical ring
is much smaller relative to the other rings (Fig. 3F). Addi-
tionally, the apex in the mutants appears obstructed by
tight junctions between cells (perhaps vulF precursors)
within the diamond-shaped ring (see arrow in Fig. 3F).
The disorganized tissue in the region of vulF, abnormal
placement of vulF nuclei at the apex of the vulva, and
abnormal jam-1::gfp fluorescence at the sides and the apex
of the vulF toroid all support the hypothesis that the
primary defect in egl-26 mutants is an abnormal vulF
morphology. Abnormal morphology of vulF then results in
a failure to make a functional connection between the
vulval and uterine lumens and an Egl phenotype.
egl-26 Encodes a Novel Protein
We cloned egl-26 using microinjection transformation to
rescue the Egl phenotype of ku211 and ku228. ku211 and
ku228 map to the left of the physical marker stP100 on
chromosome II (under Materials and Methods). We tested
cosmids covering this small physical region for rescue.
Cosmid C36F12 can efficiently restore the ability of
ku211and ku228 hermaphrodites to lay eggs when intro-
duced into mutant animals on an extrachromosomal array
(3/4 transgenic lines were rescued). The portion of C36F12
that overlaps cosmid C23H3 and a subclone, pWH11, which
encoded only the predicted gene C23H3.1, contain the
rescuing activity (under Materials and Methods, and data
not shown). A cDNA clone corresponding to C23H3.1 was
obtained from a Stratagene mixed-stage library and was
sequenced (Fig. 4A). The sequence confirmed the structure
predicted by Genefinder for C23H3.1. egl-26 is predicted to
encode a novel 317-amino-acid protein (Fig. 4A). Proving
that C23H3.1 was egl-26, the lesion associated with each of
the egl-26 alleles was determined to be associated with
missense mutations in the C23H3.1 coding region (Fig. 4A).
Two lesions, ku228 and e1952, are identical and, along with
ku211, encode proteins with glycine to glutamic acid sub-
stitutions in the central region of EGL-26. n481 encodes a
protein with a serine to phenylalanine substitution nearer
the C terminus. Although EGL-26 is a novel protein with
no striking homology to other proteins in the data base, it is
highly conserved in the closely related species Caenorhab-
ll rights reserved.
252 Hanna-Rose and HanFIG. 3. vulF adopts an abnormal morphology in egl-26 mutants. Three-dimensional reconstructions of jam-1::gfp rings in (A, C, E)
jcIs1[jam-1::gfp] and (B, D, F) egl-26(ku211); jcIS1 mid-L4-stage vulvae were created from a z-series of deconvoluted fluorescence
photomicrographs through vulvae from a (A–D) lateral or (E, F) ventral view. Letters with arrows indicate specific vulval toroids. (A, C) The
sides of vulF flare out to the apex (arrowheads), and the apex is as wide (brackets) as the widest jam-1::gfp ring. (B, D) In contrast, in mutant
animals, vulF extends straight up (arrowheads) to the apex, and the apex is approximately half as wide as the widest jam-1::gfp ring. In the
ventral views, (E) a large, diamond-shaped ring that is open in the center forms the wild-type apex. In contrast, (F) the mutant apical ring
adopts a small diamond shape with junctions inside. (G) Wild-type and (H) mutant schematic representations of the shape of the vulval
toroids as determined by jam-1::gfp ring visualization. Note the flared shape of vulF and the large size of the lumenal opening in wild type
as compared to the mutant. Bars, 5 mm.
© 2001 Elsevier Science. All rights reserved.
253egl-26 Mediates Vulval Morphogenesisditis briggsae (Butler et al., 1981). An EST from a C.
briggsae mixed-stage library encodes an incomplete protein
that is 86% identical to the C-terminal 79 amino acids of
EGL-26. (Fig. 4B).
egl-26 Acts in the 1° Vulval Lineage
egl-26 plays a vital role in the morphogenesis of a vulval
toroid, vulF, located where the vulva and the uterus con-
nect, and it appears to be expressed near the lumen of both
organs in the vicinity of vulF (see below). In order to
determine which tissue requires egl-26 activity for func-
tional morphogenesis to occur, we generated and analyzed
egl-26 mosaic animals. Mosaic analysis is facilitated in C.
FIG. 4. egl-26 encodes a predicted, novel protein of 317 amino acid
sequence is indicated below the entire cDNA sequence. “*” indica
to the initiation codon. “ Ù ” indicates the polyadenylation site, and
with each allele is indicated above the sequence, and the mutated a
a C. briggsae cDNA is 87% identical to the EGL-26 C terminus.elegans by the largely invariant lineage of the animals. A C.
© 2001 Elsevier Science. Aelegans zygote divides to produce two cells called AB and
P1. The vulva is derived entirely from the AB lineage and,
specifically, the ABpl and ABpr sublineages (Fig. 5A). In
contrast, the uterus (and the entire somatic gonad) is
derived entirely from the MS sublineage of P1 (Fig. 5A). We
created animals with wild-type vulval cells and mutant
uterine cells and vice versa to address the question of which
organ requires egl-26 activity.
Extrachromosomal DNA arrays that are formed in C.
elegans upon injection of DNA into the syncytial gonad can
be utilized for mosaic analysis because they are segregated
with less fidelity than normal chromosomes. During a cell
division, the extrachromosomal array can be lost in one
daughter and maintained in the other. When an array is lost
t is conserved in the C. briggsae genome. (A) The predicted protein
top codons. Note the two in-frame stop codons in the cDNA prior
putative poly(A) signal is underlined. The altered codon associated
acid residue is in bold. (B) A predicted, partial protein encoded bys tha
tes s
the
minoduring an early embryonic division, a mosaic animal with
ll rights reserved.
254 Hanna-Rose and Hanan entire mutant lineage is generated. We introduced an
extrachromosomal array carrying wild-type copies of the
egl-26 gene (pWH11) and copies of a sur-5::gfp fusion
construct into egl-26(ku211) mutants. pWH11 rescues the
Egl phenotype (Fig. 5B), and sur-5::gfp, which causes expres-
sion of fluorescent protein in the nucleus of almost every
cell in the hermaphrodite (Yochem et al., 1998), acts as a
cell-autonomous marker to distinguish mutant and wild-
type cells. We identified mosaics that had lost the array in
some lineage or lineages by selecting animals with less
intense fluorescence as observed in the dissecting micro-
scope. We scored a large number of cells in each mosaic
animal for nuclear fluorescence to deduce at which point in
the lineage the array had been lost (see Materials and
Methods). Once the point of loss had been determined, we
recovered the animals from the slide and scored for egg-
laying activity.
We identified a total of 17 mosaics with array losses in P1
and, thus, in the uterus. P1 mosaic animals were rescued for
egg-laying activity, indicating that egl-26 is probably not
required in the uterus or any other gonadal cell (Fig. 5B). We
identified 11 animals with a loss of the array in the AB or
ABp lineages and, thus, in the vulva. These losses resulted
FIG. 5. Mosaic analysis indicates that egl-26 activity is required
specifically in P6.p. (A) Schematic of the early C. elegans lineage.
The vulval tissue is derived from the ABp lineage, while the uterine
tissue is derived from the MS lineage. Filled pie charts indicate
proportion of rescued mosaics when a loss occurred in the indicated
lineage. (B) Egg-laying defective phenotype (% Egl) and rescue
activity (1 or 2) of nonmosaic controls and mosaic animals is
indicated. “n ” is the number of animals of each category exam-
ined. ABpl or ABpr losses result in mosaicism within the vulva, and
animals with these losses were scored for maintenance of the array
in each of the vulval lineages (i.e., for fluorescence in the P5.p, P6.p,
and P7.p lineages).in loss of egl-26-rescuing activity consistent with a function
© 2001 Elsevier Science. Afor egl-26 in the vulva (Fig. 5B). Furthermore, we were able
to determine the specific vulval lineage that required egl-26
by obtaining animals mosaic in the ABpl or ABpr lineages
which leads to mosaicism within the vulva. By incorporat-
ing the unc-36(e251) mutation, which results in an unco-
ordinated (Unc) phenotype, into the strain and an unc-36-
rescuing construct on the array, we obtained mosaic
animals with losses in ABpl or ABpr. The focus for unc-36
activity is in the ABp lineage, but animals with a loss in
only ABpl or ABpr are semiUnc (Kenyon, 1986). We selected
SemiUnc animals that retained some fluorescence from
animals carrying the unc-36(1), egl-26(1), sur-5::gfp array,
and we scored these animals as above. In this manner, we
identified a total of 15 vulval mosaics. Arrays that were
maintained in P6.p, regardless of whether they were main-
tained in the 2° vulval lineages, permitted rescue of egg-
laying activity. In contrast, arrays that were lost in P6.p
while being maintained in at least one of the vulval 2°
lineages did not mediate rescue, indicating that egl-26
activity in P6.p is necessary and sufficient for function (Fig.
5B).
EGL-26 Is Expressed in vulE and Displays a
Distinct Localization Pattern
To examine the expression pattern of egl-26, we created a
construct, pWH15, to encode a full-length functional
EGL-26::GFP fusion protein. Because pWH15 retained
egl-26 activity as assayed by ability to rescue ku211 and
ku228 mutants when expressed from an extrachromosomal
array (2/4 lines rescued), we assumed that the EGL-26::GFP
expression pattern would accurately represent global and
subcellular localization of EGL-26. In animals that carry
this fusion construct on an extrachromosomal array,
kuEx90, we observed expression in many regions of the
animal, although not ubiquitously. Expression is strong
around the cells of the spermatheca, around the mouth, and
lining the pharynx, the rectum (Figs. 6C and 6D), and the
excretory canals (data not shown). We also see expression in
the pharyngeal intestinal junction cells, transiently during
L3 in the anchor cell, in rectal epithelial cells D, VL, and
VR, in B (Figs. 6C and 6D) and in Y, and in several cells with
a neuronal appearance (data not shown). However, we
focused our attention on the expression in and around the
vulva, where the primary defect was identified and where
the mosaic experiments indicate egl-26 functions.
Expression is obvious near the vulva and the uterus only
during L4 (Figs. 6A and 6B). However, it is often very
difficult to tell which cell is actually expressing egl-26::gfp
because the fusion protein appears to line the lumen of the
uterus and portions of the vulval lumen and is not obvi-
ously associated with any particular cell cytoplasm (Figs.
6A and 6B). Even in cases where a cell cytoplasm obviously
contains egl-26::gfp, expression is often brighter around the
apical edge of the cell (see uv3 cell in Fig. 6B).
Mosaic analysis indicates that egl-26 activity in the P6.p
lineage is necessary and sufficient for function. P6.p gives
ll rights reserved.
255egl-26 Mediates Vulval MorphogenesisFIG. 6. EGL-26::GFP is expressed by vulE and has a distinct subcellular localization pattern. (A, C) Nomarski photomicrographs and (B,
D) corresponding fluorescence images of lateral view of mid-L4-stage animals carrying a functional egl-26::gfp translational fusion on an
extrachromosomal array, kuEx90. (A, B) EGL-26::GFP is tightly associated with the edge of the uterine lumen, u, and portions of the vulval
lumen, v. uv3, ventral uterine cell. (C, D) EGL-26::GFP is expressed in the B cell and lines the distal portion of the rectum. (E, F)
Fluorescence images from the left and right sides of a mid-L4-stage animal carrying an egl-26::gfp transcriptional fusion with a nuclear
localization signal on an integrated array, kuIs36. Arrowheads indicate vulE nuclei and the arrow indicates the edge of the vulB2 toroid.
(G) Nomarski photomicrograph of left lateral view of mid-L4-stage vulva showing two of the vulE nuclei (arrowheads). A 3-D reconstruction
of the egl-26::gfp translational fusion expression pattern (I) is overlaid on Nomarski photomicrograph from the same animal (G) to create
(H), demonstrating that the area of expression seen lining the central region of the vulval lumen in (B) (arrowhead) is most closely associated
with vulE (arrowheads in H). Arrow indicates the edge of the vulB2 toroid. Bars, 5 mm.
© 2001 Elsevier Science. All rights reserved.
256 Hanna-Rose and Hanrise to only vulE and vulF. Furthermore, phenotypic analy-
sis indicates that loss-of-function mutations in egl-26 result
in abnormal vulF morphology. Together, these results sug-
gest that egl-26 acts in either vulE or vulF to promote proper
morphological changes in vulF. To distinguish further be-
tween a cell-autonomous function in vulF or a non-cell-
autonomous function in vulE, we examined the expression
pattern of egl-26::gfp more closely. Because of the lack of
nuclear or cytoplasmic expression, it was difficult to deter-
mine which cells were expressing egl-26::gfp in the animals
carrying the translational fusion. Therefore, we created a
second line of transgenic animals that carried an integrated
array, kuIs36, expressing an egl-26::gfp transcriptional fu-
sion with a nuclear localization signal. This transcriptional
fusion construct is expected to cause fluorescence in the
nuclei of cells where egl-26 is normally expressed. In kuIs36
animals, it was obvious that the egl-26 promoter is active in
vulE nuclei (Figs. 6E and 6F). However, activity cannot be
detected in vulF nuclei (Fig. 6, and data not shown). Expres-
sion was reproducibly either anterior–posterior or left–right
asymmetrical in the vulE nuclei (Figs. 6E and 6F, and data
not shown). Expression is also visible in the vulB nuclei but
not in other vulval toroids (Figs. 6E and 6F, and data not
shown).
Consistent with the results from the transcriptional
fusion, we also determined that the expression observed
near the top of the vulval lumen in animals carrying the
translational fusion (arrowhead in Fig. 6B) corresponds most
closely to the position of vulE (Figs. 6G–6I). By performing
deconvolution and 3-D reconstruction on a series of fluo-
rescent images through multiple planes of mid-L4 stage
vulvae from the lateral side of kuEx90 animals, we can
visualize the 3-D expression pattern of the EGL-26::GFP
translational fusion protein (Fig. 6I). In this manner, expres-
sion is observed in a ring around the ventral region of the
vulva (arrow in Fig. 6I), in a thicker region near the center of
the vulva (arrowhead in Fig. 6I), and at the apex of the vulva
corresponding to where the utse lies separating the vulval
and uterine lumens. When this 3-D representation from Fig.
6I is overlaid on a DIC photomicrograph of the lateral side
of the same animal where the vulE nuclei are visible (Fig.
6G), it becomes obvious that the thick region of expression
in the center of the vulva closely corresponds to the vulE
cells (Fig. 6H). The ring around the ventral region of the
vulval most likely corresponds to expression by vulB2 as
assayed by the transcriptional fusion (data not shown). The
thick region in the center of the vulva when viewed from
several angles indicates that expression is localized to the
inside edge of the vulE cell, adjacent to the lumen, as well
as between the vulE nuclei where the vulE precursor cells
have not yet fused, and overlapping partially to the area on
the top and the bottom of the vulE toroid (Fig. 6G, and data
not shown). Thus, we conclude that EGL-26 is expressed in
vulE and is not detectable in vulF. Furthermore, EGL-26
becomes localized to the apical edge of the vulE cell
adjacent to the vulval lumen and perhaps to a portion of the
interface between vulE and the neighboring toroids vulD
© 2001 Elsevier Science. Aand vulF. These data suggest that this novel protein with a
distinct apical localization acts non-cell-autonomously in
determining cell morphology of vulF. Alternatively, if
EGL-26 expression level is simply too low to detect in vulF,
EGL-26 could act cell-autonomously in vulF.
DISCUSSION
By searching for genes involved in vulval morphogenesis,
we identified two alleles of egl-26. In egl-26 mutants, vulF,
the most dorsal vulval cell, develops an abnormally narrow
and occluded apex, preventing formation of the vulval-
uterine connection and resulting in an Egl phenotype.
egl-26 encodes a novel protein with a distinctive localiza-
tion pattern on the apical side of some vulval and most
uterine cells, adjacent to the vulval and uterine lumens.
Mosaic analysis demonstrated that egl-26 functions in
either vulE or vulF, but surprisingly, although the primary
defect is in vulF, egl-26 expression can only be detected in
vulE, suggesting that egl-26 acts non-cell-autonomously to
control the morphogenesis of vulF.
In the absence or reduction of EGL-26 activity, vulF
develops a narrow apex and a small or occluded opening
into the vulval lumen. One proposed model for EGL-26
function suggests that vulE directs morphological changes
in vulF in an interaction that is mediated by EGL-26. This
model predicts that we might expect vulF to adopt a
morphology similar to what is observed in egl-26 mutants
when vulE is absent. We have begun to test this model by
ablating the cells that give rise to vulE, P6.paa, and P6.paa.
Alternatively, it remains possible that, although we cannot
detect expression of egl-26 in vulF, egl-26 may function
cell-autonomously. Mosaic analysis cannot distinguish be-
tween these two possibilities, but our expression analysis
argues against a cell-autonomous model.
Although the molecular lesions that we have identified in
egl-26 mutations are not obvious molecular nulls, they act
as loss-of-function alleles in regard to vulval morphogen-
esis, allowing us to conclude that a normal function of
EGL-26 is to promote proper morphology of the vulF cell.
We propose that egl-26 is acting as a morphogenesis gene as
opposed to a specification gene. Primary vulval cell fate
appears to be properly specified in the absence or reduction
of egl-26. Furthermore, the egl-26::gfp transcriptional fusion
is still expressed in vulE, but not vulF, in an egl-26 mutant
(data not shown), suggesting that vulE fate is properly
specified in the mutant and that vulF is not simply taking
on a vulE-like fate. Consistent with a role for egl-26 after
specification of fates is complete, egl-26::gfp expression in
the vulva is not evident until relatively late in vulval
morphogenesis, during the fourth larval stage. Although
egl-26 is also expressed in vulB2, no striking morphological
role appears associated with this expression since no dra-
matic vulval morphology defects are associated with the
portion of the vulval derived from the secondary lineages in
egl-26 mutants (Fig. 2, and data not shown). We attempted
ll rights reserved.
257egl-26 Mediates Vulval Morphogenesisto use RNA inhibition (RNAi) to look for stronger pheno-
types associated with an egl-26 null mutation (Fire et al.,
1998; Guo and Kemphues, 1995). However, after trying
various RNAi methods, including injecting, feeding, and
expressing dsRNA from a tissue-specific vector, we have
been unable to observe any egl-26(RNAi) phenotype, in-
cluding the Egl phenotype associated with our egl-26 mu-
tations. RNAi also failed to significantly reduce the expres-
sion of egl-26:GFP in vulval cells (data not shown),
indicating that either the egl-26 gene or the vulval tissue is
resistant to RNAi. We have found RNAi to be ineffective in
phenocopying mutations in several genes involved in vulval
morphogenesis, some of which are known nulls (W.H.-R.,
M.H., Z. Chen, and D. Fay, unpublished observations),
suggesting that RNAi in the vulva may be inefficient at late
stages.
Control of cell shape is a complex process that is typically
highly regulated and often involves intricate cytoskeletal
and cell membrane alterations. In light of a potential
non-cell-autonomous function of egl-26 in controlling the
morphology of vulF, the localization of EGL-26 is quite
intriguing. EGL-26 appears to be tightly associated with the
apical edge of vulval cells. Expression abuts the vulval
lumen and just slightly overlaps onto the top and bottom of
the vulE toroid at the junction of vulE and vulF and vulE
and vulD, respectively. Thus, EGL-26 is in a location
permitting a potential direct (or very nearly direct) interac-
tion with the vulF cell. Alternatively, an EGL-26-mediated
signal could be propagated across the membrane by an
unknown intermediate. It is unclear from the GFP expres-
sion experiments whether EGL-26 is a cytoplasmic, extracel-
lular, or perhaps membrane-associated protein. Furthermore,
EGL-26 has no motif to explain its subcellular localization.
The expression patterns of mutant EGL-26::GFPs suggest that
localization of EGL-26 is important for function. We created
full-length functional fusions between EGL-26 proteins con-
taining the mutant lesions and GFP and assayed their expres-
sion patterns. egl-26(ku211)::gfp is not expressed well, perhaps
explaining why this lesion results in reduction of EGL-26
function (data not shown). However, egl-26(n481)::gfp is still
expressed at a relatively high level, but the localization of the
protein is disrupted. EGL-26(n481)::GFP protein is observed
throughout the vulE cell and not just at the apical edges of the
cell (data not shown). Secreted molecules such as yeast phero-
mone are known to affect the morphology of nearby cells.
However, there is no evidence that EGL-26 acts in this
manner since expression in the neighboring uterine cells and
in the anchor cell is not sufficient for function and expression
is required in the primary lineage of the vulva for function.
Morphogenesis of vulval cells has been an ongoing area of
investigation. Other screens have turned up critical players
that contribute to proper vulval morphogenesis (Herman et
al., 1999; Seydoux et al., 1993). To date, we have character-
ized three genes from our vulval morphogenesis screen:
egl-26, cog-2, and lin-40 (Chen and Han, 2001). While egl-26
and lin-40 function in the vulva, cog-2 functions in the
ventral uterus to promote formation of a functional connec-
© 2001 Elsevier Science. Ation between the two organs. In the ventral uterus, both the
uterine seam cell and the four uv1 cells make intimate
contacts with the vulva to promote structural integrity of
the uterus and the vulva and to promote proper formation of
the vulval-uterine connection. COG-2 appears to function
in the uterine seam cell (Hanna-Rose and Han, 1999). It is
clear that Notch signaling is required for specification of
both cell types and that the LIM domain transcription
factor LIN-11 is also important for proper specification
and/or morphogenesis of the uterine seam cell (Cinar et al.,
2001; Newman et al., 1999, 2000). Additionally, an EGF
signal that is regulated by the Pax family transcription
factor EGL-38 in the vulva promotes specification of uv1
cell fate (Chamberlin et al., 1997; Chang et al., 1999). The
genetic control of coordination of morphogenesis of these
two organs is clearly an area of study that is ripe for further
investigation.
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